Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Debt / NOTE 3.250%11/0
-
Number of holders
-
13
-
Total 13F principal, excl. options
-
126,300,000
-
Principal change
-
-100,000
-
Total reported value, excl. options
-
$107,237,000
-
Value change
-
-$35,229
-
Number of buys
-
2
-
Number of sells
-
-1
-
Price
-
$0.8557
Significant Holders of ENDOLOGIX INC - NOTE 3.250%11/0 as of Q2 2017
13 filings reported holding 29266SAB2 - ENDOLOGIX INC - NOTE 3.250%11/0 as of Q2 2017.
ENDOLOGIX INC - NOTE 3.250%11/0 has 13 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $126,300,000 of principal
.
Largest 10 bondholders include DEERFIELD MANAGEMENT CO ($40,500,000 of principal), Partner Fund Management, L.P. ($19,141,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($17,980,000 of principal), CITADEL ADVISORS LLC ($16,800,000 of principal), LINDEN ADVISORS LP ($11,639,000 of principal), PIONEER INVESTMENT MANAGEMENT INC ($7,000,000 of principal), Context Capital Management, LLC ($5,575,000 of principal), SSI INVESTMENT MANAGEMENT INC ($3,256,000 of principal), PRELUDE CAPITAL MANAGEMENT, LLC ($1,500,000 of principal), and WELLINGTON MANAGEMENT GROUP LLP ($1,200,000 of principal).
This table shows the top 13 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.